Search Results - "amyloid"
Suggested Topics within your search.
Suggested Topics within your search.
- Alzheimer Disease 8
- Dementia
- Diagnostic Imaging 6
- physiopathology 6
- Amyloid 3
- Brain 2
- Cholinergic Agents 2
- Cognitive Dysfunction 2
- Degeneration 2
- Depression 2
- Diagnosis 2
- Diagnostic imaging 2
- Dopamine 2
- Frontotemporal Dementia 2
- Lewy Body Disease 2
- Motor Disorders 2
- Nervous system 2
- Neurodegenerative Diseases 2
- Neurotransmitter Agents 2
- Parkinson Disease 2
- Positron-Emission Tomography 2
- Radionuclide imaging 2
- Tomography, Emission 2
- diagnostic imaging 2
-
1
Imaging amyloid now that we can see it, what does it all mean? /
Published 2010Table of Contents: “…Contents: Amyloid imaging PET tracers -- Development and validation -- Amyloid imaging in dementia -- Amyloid imaging in mild cognitive impairment -- Amyloid imaging in cognitively normal elderly -- Consequences of being amyloid-positive.…”
Get full text
Series
Electronic Video -
2
Imaging amyloid now that we can see it, what does it all mean? /
Published 2010Table of Contents: “…Contents: Amyloid imaging PET tracers -- Development and validation -- Amyloid imaging in dementia -- Amyloid imaging in mild cognitive impairment -- Amyloid imaging in cognitively normal elderly -- Consequences of being amyloid-positive.…”
Get full text
Series
Electronic Video -
3
Imaging amyloid now that we can see it, what does it all mean? /
Published 2010Table of Contents: “…Contents: Amyloid imaging PET tracers -- Development and validation -- Amyloid imaging in dementia -- Amyloid imaging in mild cognitive impairment -- Amyloid imaging in cognitively normal elderly -- Consequences of being amyloid-positive.…”
Get full text
Series
Electronic Video -
4
Neuroimaging markers in AD trials
Published 2010Table of Contents: “…Contents: Imaging in Alzheimer's Disease (AD) trials -- Increasing range of modalities to measure brain structure, function and molecular pathology of AD -- Early diagnosis, inclusion markers and measurement of progression -- MRI to measure atrophy -- PET to measure amyloid.…”
Get full text
Series
Electronic Video -
5
Neuroimaging markers in AD trials
Published 2010Table of Contents: “…Contents: Imaging in Alzheimer's Disease (AD) trials -- Increasing range of modalities to measure brain structure, function and molecular pathology of AD -- Early diagnosis, inclusion markers and measurement of progression -- MRI to measure atrophy -- PET to measure amyloid.…”
Get full text
Series
Electronic Video -
6
Neuroimaging markers in AD trials
Published 2010Table of Contents: “…Contents: Imaging in Alzheimer's Disease (AD) trials -- Increasing range of modalities to measure brain structure, function and molecular pathology of AD -- Early diagnosis, inclusion markers and measurement of progression -- MRI to measure atrophy -- PET to measure amyloid.…”
Get full text
Series
Electronic Video -
7
Molecular brain imaging (PET) in diseases with dementia
Published 2020Table of Contents: “…Contents: Brain imaging with positron emission tomography (PET) for dementia diagnosis and research -- Cerebral glucose metabolism in mild cognitive impairment, Alzheimer's disease, dementia with Lewy bodies, frontotemporal dementia & depression -- Imaging of pathological markers (beta-amyloid and tau) in Alzheimer's disease -- Imaging of neurotransmitters and receptors, in the dopaminergic and cholinergic system -- Multiple systems profiling in dementia, Parkinson's and related motor disorders.…”
Get full text
Series (Periodic reports)
Series (Neurodegenerative diseases)
Electronic Video -
8
Molecular brain imaging (PET) in diseases with dementia
Published 2020Table of Contents: “…Contents: Brain imaging with positron emission tomography (PET) for dementia diagnosis and research -- Cerebral glucose metabolism in mild cognitive impairment, Alzheimer's disease, dementia with Lewy bodies, frontotemporal dementia & depression -- Imaging of pathological markers (beta-amyloid and tau) in Alzheimer's disease -- Imaging of neurotransmitters and receptors, in the dopaminergic and cholinergic system -- Multiple systems profiling in dementia, Parkinson's and related motor disorders.…”
Get full text
Series (Periodic reports)
Series (Neurodegenerative diseases)
Electronic Video